Proscia is committed to helping the pathology community serve patients and maintain operations with digital pathology during the COVID-19 pandemic. We’re making our Concentriq platform available on-demand for remote case review and education.

Learn more about our COVID Response ProgramLink Arrow

Proscia is changing the way pathology is practiced.

Cancer research and diagnosis is being redefined by a new kind of lab: those that are realizing the promise of computational pathology to elevate the pathologist’s role in an era of increasingly personalized medicine and streamline operations to drive unprecedented results.

Proscia is pushing labs past the limits of traditional tools with its Concentriq® digital pathology platform and pipeline of AI applications. Operating at the center of the modern digital laboratory, these technologies are transforming the economics and practice of pathology, putting the power of modern, data-centric medicine to work in the fight against cancer.

Efficiency. Confidence. Computational Pathology.

Transform the practice and economics of your lab with computational applications for pathology, proven and implemented at today’s leading academic and commercial laboratories.

EXPLORE PROSCIA'S AI

Read our validation study in scientific reportsLink Arrow

Creating tools to find data — and fight cancer.

We’re on a mission to perfect cancer diagnosis with intelligent software that changes the way the world practices pathology. Proscia is bringing a fresh approach to an outdated industry, helping the world to keep pace with the increasing demand for pathology services and accelerating breakthroughs in the fight against cancer.

About ProsciaLink Arrow

A new kind of pathology is here.

Laboratories that hesitate to embrace the era of data driven medicine will be left behind. With AI powered pathology, we’re helping labs pursue limitless possibilities for their business, customers, and patients.

Redefining pathology

Our website uses cookies. By using this site, you agree to its use of cookies.